Increased Risk of Myocardial Infarction in Inclusion Body Myositis: A Non‐Concurrent Cohort Study
Open Access
- 29 April 2025
- journal article
- Published by Wiley in European Journal of Neurology
- Vol. 32 (5) , e70177
Abstract
Background: Idiopathic inflammatory myopathies, beyond inclusion body myositis (IBM), have demonstrated an increased risk of adverse cardiovascular outcomes, particularly myocardial infarction (MI). This study evaluated the risk of cardiovascular disease in IBM.Methods: We conducted a non‐concurrent cohort study utilizing the expanded Rochester Epidemiologic Project, including 50 patients with IBM, matched 1:6 to age‐, sex‐, and calendar year‐matched referents without IBM. Baseline cardiovascular risk factors were recorded. Differences in baseline covariates were adjusted by the inverse probability of treatment weighting method. Participants were followed from the index date forward to determine relative risks (RR) and hazard ratios (HR) for the development of cardiovascular outcomes including MI, ischemic stroke, cardiomyopathy, congestive heart failure (CHF), and peripheral vascular disease (PVD).Results: 50 patients with IBM and 294 matched population referents were included. Baseline cardiovascular risk factors were similar between groups. Aspirin use was more common (28% vs. 18%, p = 0.03) and statin use less common (26% vs. 38%, p = 0.04) in IBM versus referents. Patients with IBM had an increased hazard of MI compared to referents [HR: 5.79, 95% CI (2.51, 13.36)]. The risk of MI remained consistently elevated across all models, after accounting for potential confounders. For PVD, 16/50 IBM patients versus 16/287 referents were excluded due to pre‐existing PVD at index (p < 0.001). Among remaining participants, RR for PVD was 2.38 (0.82, 6.9). IBM was not associated with an increased risk of ischemic stroke, cardiomyopathy, or CHF.Conclusions: IBM is associated with increased risk of MI compared to population referents. Heightened cardiovascular monitoring and prevention strategies are needed in IBM.Keywords
Funding Information
- National Institute on Aging
- Center for Clinical and Translational Science, Mayo Clinic
This publication has 52 references indexed in Scilit:
- Autophagy limits acute myocardial infarction induced by permanent coronary artery occlusionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2011
- Idiopathic inflammatory myositis is associated with a high incidence of hypertension and diabetes mellitusInternational Journal of Rheumatic Diseases, 2010
- The heart in sporadic inclusion body myositis: a study in 51 patientsJournal of Neurology, 2009
- Epidemiology of sporadic inclusion body myositis and polymyositis in Olmsted County, Minnesota.2008
- Study of idiopathic inflammatory myopathies with special reference to borderland between idiopathic inflammatory myopathies and muscular dystrophiesNeurology India, 2008
- Inflammation: A pivotal link between autoimmune diseases and atherosclerosisAutoimmunity Reviews, 2006
- Inflammation, Atherosclerosis, and Coronary Artery DiseaseNew England Journal of Medicine, 2005
- Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of First-Time acute myocardial infarctionThe American Journal of Cardiology, 2004
- Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosusArthritis & Rheumatism, 2001
- Age-specific Incidence Rates of Myocardial Infarction and Angina in Women with Systemic Lupus Erythematosus: Comparison with the Framingham StudyAmerican Journal of Epidemiology, 1997